2649 E Mulberry St Ste 3 Fort Collins, CO 80524 1231
Note: Revenues for privately held companies are statistical evaluations.
Atlas Biologicals's annual revenues are $1-$10 million (see exact revenue data) and has 1-10 employees. It is classified as operating in the Management, Scientific & Technical Consulting Services industry.
Note: Atlas Biologicals's revenues are gauged from an analysis of company filings.
Atlas Biologicals's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Atlas Biologicals Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Atlas Biologicals is developing and marketing.
Atlas Biologicals doesn't have any recent trademark applications, indicating Atlas Biologicals is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
FETALCHOICE Animal blood sera and serum components for scientific or medical research use
08/20/2014
PROGENISERUM Animal blood sera and serum components for scientific research and medical use
03/06/2012
FETAL+ Animal blood sera and serum components for scientific or medical research use
04/22/2010
See all trademarks and details in the Full Report.
Recession Risk
Determine whether Atlas Biologicals grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Atlas Biologicals is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Atlas Biologicals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Atlas Biologicals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Atlas Biologicals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Atlas Biologicals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.